Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey

被引:26
|
作者
Zhou, Yang [1 ]
van den Hof, Susan [2 ,3 ]
Wang, Shengfen [1 ]
Pang, Yu [1 ]
Zhao, Bing [1 ]
Xia, Hui [1 ]
Anthony, Richard [4 ]
Ou, Xichao [1 ]
Li, Qiang [1 ]
Zheng, Yang [1 ]
Song, Yuanyuan [1 ]
Zhao, Yanlin [1 ]
van Soolingen, Dick [4 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
[2] KNCV TB Fdn, The Hague, Netherlands
[3] Amsterdam Med Ctr, Dept Global Hlth, Pietersbergweg 17, Amsterdam, Netherlands
[4] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 03期
关键词
LARGE SEQUENCE POLYMORPHISMS; GENETIC DIVERSITY; BEIJING GENOTYPE; EVOLUTION; ORIGIN; CLONE; SUBLINEAGES; PULMONARY; RIFAMPIN; INSIGHTS;
D O I
10.1371/journal.pone.0174197
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We describe the population structure of a representative collection of 3,133 Mycobacterium tuberculosis isolates, collected within the framework of a national resistance survey from 2007 in China. Genotyping data indicate that the epidemic strains in China can be divided into seven major complexes, of which 92% belonged to the East Asian (mainly Beijing strains) or the Euro-American lineage. The epidemic Beijing strains in China are closely related to the Beijing B0/W148 strain earlier described in Russia and a large cluster of these strains has spread national wide. The density of Beijing strains is high in the whole of China (average 70%), but the highest prevalence was found North of the Yellow river. The Euro-American lineage consists of three sublineages (sublineage_1, 2, and 3) and is more prevalent in the South. Beijing lineage showed the highest cluster rate of 48% and a significantly higher level of resistance to rifampicin (14%, p < 0.001), ethambutol (9%, p = 0.001), and ofloxacin (5%, p = 0.011). Within the Euro-American Lineage, sublineage_3 revealed the highest cluster rate (28%) and presented a significantly elevated level of resistance to streptomycin (44%, p < 0.001). Our findings suggest that standardised treatment in this region may have contributed to the successful spread of certain strains: sublineage_3 in the Euro-American lineage may have thrived when streptomycin was used without rifampicin for treatment, while later under DOTS based treatment, in which rifampicin plays a key role, Beijing lineage appears to be spreading.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Mycobacterium culturing and drug resistance of osteoarticular tuberculosis in Xinjiang, China
    Hajiaheman, Yeerzati
    Yang, Yi
    Shayilanbieke, Nuerhanati
    Jin, Gele
    MEDICINE, 2020, 99 (16)
  • [32] Multi-drug resistance of Mycobacterium tuberculosis strains in Tianjin, China from 2006 to 2015
    Li-Xia, Zhang
    Zhong-Hua, Qin
    Hai-Bai, Sun
    Min, Wu
    Qi, Wu
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (10): : 4594 - 4598
  • [33] Genetic diversity and drug resistance of Mycobacterium tuberculosis in Yunnan, China
    Li, Daoqun
    Song, Yuzhu
    Yang, Pengpeng
    Li, Xiaofei
    Zhang, A-Mei
    Xia, Xueshan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (05)
  • [34] Mycobacterium tuberculosis drug resistance, Ghana
    Owusu-Dabo, Ellis
    Adjei, Ohene
    Meyer, Christian G.
    Horstmann, Rolf D.
    Enimil, Anthony
    Kruppa, Thomas F.
    Bonsu, Frank
    Browne, Edmund N. L.
    Chinbuah, Margaret Amanua
    Osei, Ivy
    Gyapong, John
    Berberich, Christof
    Kubica, Tanja
    Niemann, Stefan
    Ruesch-Gerdes, Sabine
    EMERGING INFECTIOUS DISEASES, 2006, 12 (07) : 1170 - 1172
  • [35] Mechanisms of Mycobacterium tuberculosis Drug Resistance
    Shulgina, M. V.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2024, 39 (01) : 1 - 13
  • [36] The road to drug resistance in Mycobacterium tuberculosis
    Koch, Anastasia
    Wilkinson, Robert John
    GENOME BIOLOGY, 2014, 15 (11):
  • [37] Mycobacterium tuberculosis drug resistance, Abkhazia
    Pardini, M
    Iona, E
    Varaine, F
    Karakozlan, H
    Arzumanian, H
    Brunori, L
    Orefici, G
    Fattorini, L
    EMERGING INFECTIOUS DISEASES, 2005, 11 (03) : 501 - 503
  • [38] Mechanisms of drug resistance in mycobacterium tuberculosis
    Wade, MM
    Zhang, Y
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 975 - 994
  • [39] The road to drug resistance in Mycobacterium tuberculosis
    Anastasia Koch
    Robert John Wilkinson
    Genome Biology, 15
  • [40] Development of drug resistance in Mycobacterium tuberculosis
    Bergval, Indra L.
    Anthony, Richard M.
    Schuitema, Anja R.
    Oskam, Linda
    Klatser, Paul R.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 118 - 118